Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivors

Clinical Endocrinology

Volumn 76, Issue 4, 2012, Pages 582-585

  Polotsky, Hanah N ^a,b   Brokhin, Matvey ^a   Omry, Gal ^a   Polotsky, Alex J ^c   Tuttle, R Michael ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Colorado Permanent Medical Group ^*  (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN;

AGING; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CANCER HORMONE THERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROIDECTOMY; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVORS; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; WEIGHT LOSS;

EID: 84857819318     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04264.x     Document Type: Article

References (21)

1. Hill, J.O. (2006) Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocrine Reviews, 27, 750-761.
2. Macias, A.E. (2004) Experimental demonstration of human weight homeostasis: implications for understanding obesity. British Journal of Nutrition, 91, 479-484.
3. Hoogwerf, B.J. & Nuttall, F.Q. (1984) Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. American Journal of Medicine, 76, 963-970. (Pubitemid 14120399)
4. Lonn, L., Stenlof, K., Ottosson, M. et al. (1998) Body weight and body composition changes after treatment of hyperthyroidism. Journal of Clinical Endocrinology & Metabolism, 83, 4269-4273. (Pubitemid 29100120)
5. Jacobsen, R., Lundsgaard, C., Lorenzen, J. et al. (2006) Subnormal energy expenditure: a putative causal factor in the weight gain induced by treatment of hyperthyroidism. Diabetes Obesity & Metabolism, 8, 220-227.
6. Abid, M., Billington, C.J. & Nuttall, F.Q. (1999) Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. Journal of the American College of Nutrition, 18, 189-193. (Pubitemid 29157327)
7. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A. et al. (2005) Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clinical Endocrinology, 62, 487-491.
8. Tigas, S. et al. (2000) Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid, 10, 1107-1111. (Pubitemid 32095081)
9. DelaRosa, R.E., Hennessey, J.V. & Tucci, J.R. (1997) A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis. Thyroid, 7, 401-405. (Pubitemid 27295138)
10. Dubois, S., Abraham, P., Rohmer, V. et al. (2008) Thyroxine therapy in euthyroid patients does not affect body composition or muscular function. Thyroid, 18, 13-19. (Pubitemid 351170441)
11. Roti, E. et al. (1993) The use and misuse of thyroid-hormone. Endocrine Reviews, 14, 401-423.
12. Smith, B.R., Cooper, D.S., Doherty, G.M. et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109-142.
13. Luster, M. et al. (2005) Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirtypatient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration. Thyroid, 15, 1147-1155. (Pubitemid 41720721)
14. Schroeder, P.R., Haugen, B.R., Pacini, F. et al. (2006) A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. Journal of Clinical Endocrinology and Metabolism, 91, 878-884. (Pubitemid 43357753)
15. Robbins, R.J. & Robbins, A.K. (2003) Recombinant human thyrotropin and thyroid cancer management. Journal of Clinical Endocrinology and Metabolism, 88, 1933-1938. (Pubitemid 36549859)
16. Sheehan, T.J. et al. (2003) Rates of weight change for black and white Americans over a twenty year period. International Journal of Obesity and Related Metabolic Disorders, 27, 498-504. (Pubitemid 36520850)
17. Shimokata, H., Andres, R., Coon, P.J. et al. (1989) Studies in the distribution of body fat. II. Longitudinal effects of change in weight. International Journal of Obesity, 13, 455-464.
18. Van Wye, G. et al. (2007) Weight cycling and 6-year weight change in healthy adults: the aerobics center longitudinal study. Obesity (Silver Spring), 15, 731-739. (Pubitemid 46643327)
19. Lin, S.Y., Huang, S.C. & Sheu, W.H. (2010) Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal. Metabolism, 59, 195-199.
20. Arterburn, D., Ichikawa, L., Ludman, E.J. et al. (2008) Validity of clinical body weight measures as substitutes for missing data in a randomized trial. Obesity Research and Clinical Practice, 2, 277-281.
21. Kaptein, E.M., Beale, E. & Chan, L.S. (2009) Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. Journal of Clinical Endocrinology and Metabolism, 94, 3663-3675.